Daunorubicin 30 mg/ m2 i. v., dag 1- 3, 15- 16; VCR 2 mg total dose i. v., dag 1, 8, 15, 22; CP 750 mg/ m2 i. v., dag 1, 8; prednison 60 mg/ m2 oral, dag 1- 7, 15- 21; IDA 9 mg/ m2 oral, dag 1- 28; MTX 15 mg intrathecal, dag 1, 8, 15, 22; Ara- C 40 mg intrathecal, dag 1, 8, 15, 22; methylprednisolon 40 mg intrathecal, dag 1, 8, 15, 22
consolidation II, IV Etude AAU02 Traitement d’ induction (LAL Ph+ de novo) Consolidation (LAL Ph+ de novo) Etude ADE04 Pré-phase Traitement d’ induction I Traitement d’ induction II Traitement de consolidation Etude AJP01 Traitement d’ induction